About Pythia Biotech Ltd.
At Pythia Biotech Ltd., we harness innovative technologies to improve human health and well-being and promote sustainable ecological development. Our vision is to redefine the future of medical care.
Our Foundation and Achievements
Founded in 2022 by a team of clinical and engineering experts, Pythia Biotech Ltd. has quickly established itself as a leader in biotechnology. In 2023, we proudly received technology transfer support from National Tsing Hua University and Taipei Medical University. Our commitment to excellence has earned us multiple international awards, and we’ve formed a strategic partnership with Merck, a global leader in pharmaceuticals.
Our core focus is on leveraging cutting-edge organ-on-chip technology to create precise and safe ex vivo testing environments. This innovative approach accelerates the drug development process, enabling us to bring transformative therapies to market more efficiently.
Join us on our journey to revolutionize healthcare and enhance the well-being of communities around the world.
Gain global recognition
In 2025 and 2026, we were proud to participate in the MOEA A+ Industrial Innovative R&D Program.
Pythia Biotech Ltd. was honored to receive the 21ᵗʰ National Innovation Award in the Startups.
(Biopharmaceuticals and Precision Medicine)
In 2024, we proudly participated in the MOEA Startup Value Creation Program.
Pythia Biotech Ltd. was honored to receive the 18ᵗʰ, 19ᵗʰ and 20ᵗʰ National Innovation Award in the category of Precision Health (Biotech & New Drug Development).
In 2021, Pythia Biotech Ltd. was proud to receive the Future Tech Award, recognizing our groundbreaking contributions to biotechnology and innovation.
In 2020, Pythia Biotech Ltd. was granted a seed grant from the Ministry of Science and Technology (MOST).
In 2023, we proudly signed a Memorandum of Understanding (MOU) with Merck, initiating a collaborative exploration of organ-on-a-chip technology.
Pythia Biotech Ltd. was recognized as one of the Top 12 Start-ups in the 2022 Dusseldorf Medica Healthcare Innovation World Cup.
In 2022, Pythia Biotech Ltd. was honored to be part of the Boehringer Ingelheim “Grass Roots” Support Program.
Our team
Our professional team is committed to innovation and development
Previous
- Former Vice Chairman-Petrochemical Industry Association of Taiwan.
- Former President-USI Corporation and CPDC.
Education
- MSc of Business Administration at Andrews University.
- Bsc in Chemistry at National Tsing Hua University.
Previous
- YCM Products Co. Ltd. Director Global Customer Success.
- United Microelectronics Corporation Assistant Manager, Product Marketing.
Education
- Ph.D. in Institute of Nanoengineering & Microsystems at National Tsing Hua University.
Previous
- Postdoc researcher in Department of Biomedical at National Taiwan University.
- Research Assistant in National Taiwan University Hospital.
- Product Specialist in Bio genesis Technologies, lnc.
Education
- Ph.D. in Department of Biomedical at National Taiwan University.
Previous
- Research Assistant in Institute of Nanoengineering & Microsystems, National Tsing Hua University.
Education
- MSc in Molecular Biomedicine at National Cheng Kung university.
Previous
- PM of TFDA.
- Research Assistant in National Dong Hwa University.
Education
- Bsc in Chemistry at National Dong Hwa University.
Financial
Aminy Chen
Previous
- CFO, Hamstec Biotechnology.
- Manager, CPDC.
Education
- MSc in Economics at National Dong Hwa University.
PATRNERSHIP
Our excellent partners
CONTACT US
Contact us
We sincerely look forward to hearing from you and contacting you.
service@pythiabiotech.com
Telephone
Monday-Friday 9:00-18:00
+886-2-2653-8685#2018
Office
Rm. C311, Unit C, No. 99, Ln. 130, Sec. 1, Academia Rd.,
Nangang Dist., Taipei City 115,
Taiwan (R.O.C.)